Connecting with the industry, driving innovation in Life Sciences
Upcoming events
April 23rd, 2027
NYC
i2e Elevate 2027
i2e Elevate returned for its third edition in 2027, bringing together senior R&D, portfolio, and clinical operations leaders for an invitation-only forum focused on candid peer discussions, practical insights, and expert-led dialogue. The forum explored how pharma organizations can align portfolio strategy with confident execution, while navigating resource planning, scenario planning, portfolio governance, and the evolving role of data and technology in enabling better decisions.
i2e Consulting will be at the ACDM RBQM Symposium 2026 in Dublin, now in its fourth year, where professionals from pharma, CROs and technology providers come together for case studies, panel discussions and peer networking. On November 10, i2e presents its session on moving from data availability to data usability, exploring how analysis-ready datasets support more consistent risk signals across studies and lay the groundwork for risk-based data management.
i2e Consulting was a sponsor at the EP3M Summit 2026, which brought together pharma and biotech leaders to explore the future of project, program, and portfolio management. As R&D portfolios grow more complex, organizations need greater visibility, alignment, and data-driven insights for better decisions. We shared how PPM, analytics, resource management, and AI can enable better R&D decisions, and we’re grateful to everyone who connected with us there.
i2e Consulting was at WHY Summit Hyderabad 2026, where pharma leaders and PPM professionals explored smarter approaches to portfolio strategy, resource planning, and decision making. We also presented Agentic Resource Management (ARM) and how dynamic resource forecasting can help R&D teams respond to changing portfolios, demand, and capacity.Thank you to everyone who connected with us there.
The AI R&D Portfolio Management Meetup brings together senior pharma and R&D leaders for focused discussions on AI driven portfolio decisions, connected planning strategies, and practical approaches shaping the future of pharma innovation and clinical operations.